✦ LIBER ✦

BSC-1 Growth Inhibitor/Type β Transforming Growth Factor is a Strong Inhibitor of Thymocyte Proliferation

✍ Scribed by Hans-Jürgen Ristow

Book ID: 123632976
Publisher: National Academy of Sciences
Year: 1986
Tongue: English
Weight: 458 KB
Volume: 83
Category: Article
ISSN: 0027-8424
DOI: 10.2307/27673

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Type β Transforming Growth Factor is an

Type β Transforming Growth Factor is an Inhibitor of Myogenic Differentiation

✍ Joan Massagué, Sela Cheifetz, Takeshi Endo and Bernardo Nadal-Ginard 📂 Article 📅 1986 🏛 National Academy of Sciences 🌐 English ⚖ 674 KB

Transforming growth factor-β and glucoco

Transforming growth factor-β and glucocorticoid regulation of plasminogen activator inhibitor type-1

✍ P.A. Andreasen; L.R. Lund; A. Riccio; L.S. Nielsen; P. Kristensen; M. Laiho; K.G 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 101 KB

Transforming growth factor type β is a s

Transforming growth factor type β is a specific inhibitor of 3T3 T mesenchymal stem cell differentiation

✍ Rodney L. Sparks; Robert E. Scott 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 623 KB

Purification of platelet-derived endothe

Purification of platelet-derived endothelial cell growth inhibitor and its characterization as transforming growth factor-βtype 1

✍ St. Magyar-Lehmann; P. Böhlen 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 621 KB

Insulin-Like Synergistic Stimulation of

Insulin-Like Synergistic Stimulation of DNA Synthesis in Swiss 3T3 Cells by the BSC-1 Cell-Derived Growth Inhibitor Related to Transforming Growth Factor Type β

✍ Kenneth D. Brown and Robert W. Holley 📂 Article 📅 1987 🏛 National Academy of Sciences 🌐 English ⚖ 955 KB

Transforming growth factors type β1 and

Transforming growth factors type β1 and β2 are equipotent growth inhibitors of human breast cancer cell lines

✍ Gerhard Zugmaier; Bruce W. Ennis; Bernd Deschauer; Deborah Katz; Cornelius Knabb 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 735 KB

At least one member of the TGF-P family, TGF-p1, has been previously shown to inhibit the anchorage-independent growth of some human breast cancer cell lines (Knabbe et al., 1487; Arteaga et al., 1988). Members of the TGF-P family might, [herefore, provide new strategies for breast cancer therapy. W